Carestream Health Announces Distribution Agreement with DMS Group in France

Carestream HealthCarestream Health in France has signed a distribution agreement with Apelem, a subsidiary of the DMS Group in France. Under the terms of the agreement, Carestream can sell two new Platinum remote controlled radiographic tables developed by Apelem exclusively to customers in France and Belgium.

"We are extremely proud that Carestream Health, a world leader in the medical imaging field, should show interest in our new remote controlled radiographic table solution. This distribution contract is testament to the technological excellence of the Platinum table and confirms its major potential in the radiography market," said Jean-Paul Ansel, Managing Director of DMS. "Given the commercial power of Carestream Health, we believe that this agreement will represent a major component of growth for the next several years."

Distribution of the new Platinum dRF model with a fixed detector and the Platinum model with mobile detector and wireless functionality will complement the CARESTREAM DRX-1 family of highly productive capture systems for digital radiography. Founded on the wireless, cassette-size CARESTREAM DRX-1 detector, this portfolio currently includes the DRX-1 System that can convert analogue X-ray rooms to DR technology in less than one day; the DRX-Mobile Retrofit kit to upgrade mobile X-ray systems to wireless DRX-1 technology and a fully automated DRX-Evolution suite that offers virtually unlimited patient positioning.

"The agreement reached with DMS will enable us to offer a complete range of medical imaging systems to our French and Belgian customers”, said Anton Graule, European Sales & Business Development Manager, Medical Imaging Solutions, Carestream Health. "We have been particularly impressed by the technical capabilities of the Platinum radiographic table, as well as by its design and the diagnostic aids developed by DMS which make this table unique in its market."

Related news articles:

About Diagnostic Medical Systems
Specialising in high technology medical diagnostic solutions, Groupe DMS currently ranks number one in France in the development, design and manufacture of dedicated digital and conventional imagery radiology systems as well as bone mineral density testing. The Group's strategy, principally based on technological innovation, enables it to offer a complete range of medical imaging systems. Its representation on all continents, thanks to a network of 80 national distributors, subsidiaries and joint venture partners brings, for Groupe DMS, an international dimension to the quality of its products. DMS products are aimed at hospitals, clinics, radiologists and specialist medical practitioners who use diagnostic tools (rheumatoid and orthopaedic practitioners, gynaecologists etc). DMS has a listing in section C of the Euronext Paris market of NYSE Euronext - Code ISIN : FR 0000063224 - Mnemonic Code: DGM
DMS Contact: Nicolas BOUCHEZ, 0033 (0)1 77 35 04 37

About Carestream Health
Carestream Health is a world supplier of medical and dental imaging systems and medical computer solutions; molecular imaging systems for life science research and drug development; radiographic films and digital systems for the non-destructive testing market. For more information on the wide range of products, solutions and services, please contact your Carestream Health representative or visit the web site: www.carestreamhealth.com.

CARESTREAM is a trade mark of Carestream Health

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...